As I prepared to board the plane to Amsterdam for the Alzheimer’s Association International Conference, an email from the news site Axios caught my…
AMSTERDAM — When we arrived at the Rijks Museum, the home of Netherland’s most cherished artwork and cultural heritage, the halls were pretty empty…
Recently, Eli Lilly announced that their anti-amyloid drug solanezumab failed to prevent Alzheimer’s in cognitively healthy older individuals who showed amyloid plaque accumulation in…
Scientists still don’t know what causes Alzheimer’s, but they do have one, long-standing theory: the amyloid hypothesis. Some say it’s on the brink of…
The approval of the controversial anti-amyloid drug Aduhelm last year marked a major milestone for Alzheimer’s research — it became the first new drug…
Canine cognitive dysfunction looks a lot like Alzheimer’s and dementia in humans. Could a disease-modifying intervention that seems effective our furry companions also work for…
The media is reporting that recent fraud allegations undermine the leading theory about the cause of Alzheimer’s. But some of the field’s most established…
Dozens of drugs designed to target and clear beta-amyloid plaques in the brain have failed to prevent or halt the progression of Alzheimer’s disease….
Drugmaker Biogen had high hopes for its landmark Alzheimer’s medication Aduhelm. But ever since its controversial July 2021 approval by the Food and Drug…
Vaccines are considered one of the greatest innovations in medical history. Immunizations help train the body’s immune system to recognize and respond to a…
Human clinical trials kick off for Protollin, an experimental Alzheimer’s vaccine. After two decades of research and development, Brigham and Women’s Hospital has initiated…
The Centers for Medicare and Medicaid Services will limit Aduhelm coverage to only participants in approved clinical trials. Major U.S. healthcare providers have refused…
Vaccines are one of the greatest medical advances in history. This strategy is now being applied to the treatment and prevention of Alzheimer’s. We…
Scientists have their eyes set on spotting Alzheimer’s early. The earlier the disease can be diagnosed, the better the chance that a combination of…
On the brink of a new year, a note from Being Patient Founder and Editor-in-Chief Deborah Kan. Dear readers, As I reflect on 2021,…